Four major 2026 neurocritical care trials, summarized in full CCR 11-part format — spanning intracerebral hemorrhage, basilar artery occlusion, medium-vessel-occlusion stroke, and viral encephalitis.
FASTEST — Recombinant Factor VIIa for Intracerebral HemorrhageTRACE-5 — Tenecteplase for Basilar Artery Occlusion within 24hORIENTAL-MeVO — Endovascular Treatment of Medium-Vessel-Occlusion StrokesDexEnceph — Adjunct Dexamethasone in HSV Encephalitis🧠